Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Proactis Holdings Plc LSE:PHD London Ordinary Share GB00B13GSS58 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 36.00 35.00 37.00 36.00 35.50 36.00 144,890 08:00:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 54.1 -25.8 -27.9 - 34

Proactis Share Discussion Threads

Showing 3101 to 3124 of 9925 messages
Chat Pages: Latest  133  132  131  130  129  128  127  126  125  124  123  122  Older
DateSubjectAuthorDiscuss
29/4/2019
08:48
EezyMunny seems to have an intriguing grudge against PHD...wonder what the background is!?Don't see how anyone can be too bearish on a company capped at 50% of its revenue in a highly rate sector (trading on 3-10x revenue)
cynical sid
29/4/2019
08:48
Time will come when undervaluation will be combined with being unloved and in an uptrend - great when that happens. Needs time to address debt and get growth moving again and APF running. Look for Autumn news around Re-Think UK 2019 imho.
p1nkfish
29/4/2019
08:45
If there is share price weakness in the near term henceforward it's now down to speculators becoming bored and realising they have to hold so selling and moving on. No bad thing. All the others are already out.
p1nkfish
29/4/2019
08:43
Nonsense about obfucation, they have laid cards on the table.
p1nkfish
29/4/2019
08:43
Just email the company, they are happy to share debt covenant terms (although not exact definitions of how items like EBITDA are calculated).
durthur
29/4/2019
08:42
If they were close to breaching covenants, why would HSBC have committed another £20m for APF? And again, why would directors have been buying??
cynical sid
29/4/2019
08:42
Obfuscation this morning … only delaying the inevitable Mr Market always wins
buywell3
29/4/2019
08:40
The customers, sale cycle, average contract, ARR etc etc are very similar. The companies have worked together and similar history PHD valued at £27m with directors buyingPRSM valued at £1.5bn with directors selling
cynical sid
29/4/2019
08:38
They have a £50M Debt facility of which they have drawn about £39.5M and are within covenants. They can whittle away at that. Meanwhile the below is worth re-reading as HSBC have offered up £20M for the start/test that doesn't look like a PHD liability so not part of the £50M facility and not yet drawn anyway. PHD take a fee, probably not offering credit. A UNIQUE OFFERING according to HSBC. "The Group intends to offer an accelerated payment service to suppliers to facilitate growth or working capital benefits in return for a small discount. This opportunity has been previously deferred because of the technology transition referred to in the previous paragraph. The Board considers that this is a significant opportunity and the Group is now in a position to pursue it vigorously with new resource being recruited and permanent re-allocation of existing capacity planned." "The technology and commercial model acquired with Perfect is much more advanced than Proactis’ own equivalent technology and commercial model and the Board believes that the realisation of the supplier opportunity within the Proactis customer base will, as a result, be de-risked through the adoption of this technology and commercial model."
p1nkfish
29/4/2019
08:38
The truth of the matter IMO is that bigger holders are now locked in The first to try to bail could trigger others to do likewise Coming global macro events could soon trigger such actions IMO
buywell3
29/4/2019
08:35
They haven't breached covenants, possibly because the bank was daft enough (IMO) to put EBITDA based covenants in. Given the current situation PHD really OUGHT to tell investors the whole story re the debt (most companies detail it in the AR) IMO. You can bet they are having some very difficult conversations with their banks IMO. PRSM a completely different sector FFS - robotic process automation. PHD is in eprocurement. They are simply poles apart. lolololol
eezymunny
29/4/2019
08:33
I read the results several times this morning. Not really negative but not that positive either so decided to sell to use the money elsewhere. Be surprised if there's any wild swings in the price unless the directors pile in for shares which would be a good sign and I would then buyback some
dave4545
29/4/2019
08:29
If they were breaching their covenants, why would the directors be buying at 2x this price? They would just do a placing and invest in that
cynical sid
29/4/2019
08:26
Why plain stupid?? What is so different about their offerings, business model, customer base etc etc
cynical sid
29/4/2019
08:20
A comparison with PRSM is just plain stupid. 1.5m free cash flow vs that debt is a disaster IMO and stinks of placing to come. Why is there still no covenants detail in the narrative? I can guess that covenants are base on adj EBITDA (lolololol IMO) but when the loans expire you can bet your life (IMO) that EBITDA won't be seen within 5000000 miles of the covenant statement for any new loans :)
eezymunny
29/4/2019
08:10
The Interims were better than I expected and they haven't dodged ditching the divi to address debt and a new CFO who has some decent background internationally and most likely stress tested at Pace. Good tight knit northern management team in the offing to clear out under performance, US BS & get German and French operations in line with UK & Netherlands. Recovery has started.
p1nkfish
29/4/2019
08:08
It's generating cash It has ARR of £47m which is loads of headroom to drive bottom line and improve cashBlue Prism is loss making and valued at 50x PHD
cynical sid
29/4/2019
08:06
Of course they can & will.
p1nkfish
29/4/2019
08:05
The 7m cash is totally drowned by the debt FFS. The balance sheet is an a desperate desperate state IMO. Working cap deficit grown to 11m (that's a short term problem, hence likely placing IMO, 20-40m?), and they have deferred income 18m - that's cash they've already received for work to be done in future!). It is IMO absolutely teetering, but who knows maybe they can turn it around.
eezymunny
29/4/2019
08:03
CS, totally agree. One to put in bottom draw and forget whilst the storm passes. New CFO, X-Pace, must know a thing or two about coping with turbulence. Hope whomever wants to sell does so this week to finally clear the decks.
p1nkfish
29/4/2019
08:00
This is good, no nasty surprises. We can rebuild from hereARR of £47m is great, almost same as Blue Prism which is £1.4bnAnd then for the APF and an emerging fintech story...
cynical sid
29/4/2019
07:58
The market will decide what this is Is it a company in trouble Does it need a new CEO that can spot a bargain buy and not overpay Mr Market will now decide
buywell3
29/4/2019
07:58
Hahah, battle of the shorters vs those with a bit of faith, Eezy, you did read the balance sheet that stated they had £7m of cash? Why would a placing be required at a 66% discount to the current price?
74tom
29/4/2019
07:57
The outcome of the review looks sensible, but cash collection as a % of revenue has deteriorated over the last year. Account receivables to Jan 19 are £26.5m, or 95.6% of the £27.7m revenue. The corresponding figure for H1 last year was £18.9m and £26.3m or 71.8%. I like the underlying business, but there appears to be a lot of work to do here.
eagle eye
Chat Pages: Latest  133  132  131  130  129  128  127  126  125  124  123  122  Older
ADVFN Advertorial
Your Recent History
LSE
PHD
Proactis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200712 09:33:49